Mark R. Nathan
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 3
-
- Renal cell carcinoma treatment 1
- Advanced Breast Cancer Therapies 1
- Co-authors
- Peter Schmid (2 shared papers)Paul Nathan (1 shared paper)Martin Gore (1 shared paper)Victoria L. Bridgeman (2 shared papers)Jonathan Welti (1 shared paper)Natasha Preece (1 shared paper)Elaine Y. Wan (1 shared paper)Peter Vermeulen (2 shared papers)
- Journals
- Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)The Breast (1 paper)Oncology and Therapy (1 paper)
- Partner nations
- United KingdomBelgium
In The Last Decade
Mark R. Nathan
5 papers receiving 211 citations
Peers
Comparison fields: 5 of 49
- Oncology 62
- Cancer Research 33
- Toxicology 7
- Genetics 50
- Pulmonary and Respiratory Medicine 46
Countries citing papers authored by Mark R. Nathan
This map shows the geographic impact of Mark R. Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Nathan more than expected).
Fields of papers citing papers by Mark R. Nathan
This network shows the impact of papers produced by Mark R. Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Nathan. The network helps show where Mark R. Nathan may publish in the future.
Co-authors
The 23 scholars most cited alongside Mark R. Nathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 135 | |
| 2 | 2015 | 40 | |
| 3 | 2017 | 34 | |
| 4 | 2023 | 2 | |
| 5 | 2016 | 1 |
About Mark R. Nathan
Mark R. Nathan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Epidemiology, having authored 5 papers that have together received 212 indexed citations. Recurring topics across this work include Multiple and Secondary Primary Cancers (1 paper), Estrogen and related hormone effects (1 paper), Renal cell carcinoma treatment (1 paper), Cancer Genomics and Diagnostics (1 paper), Immunotherapy and Immune Responses (1 paper), Melanoma and MAPK Pathways (1 paper), Liver physiology and pathology (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Oncology (62 citations), Cancer Research (33 citations), Toxicology (7 citations), Genetics (50 citations) and Pulmonary and Respiratory Medicine (46 citations). Mark R. Nathan has collaborated with scholars based in United Kingdom and Belgium. Frequent co-authors include Peter Schmid, Paul Nathan, Martin Gore, Victoria L. Bridgeman, Jonathan Welti, Natasha Preece, Elaine Y. Wan, Peter Vermeulen, Caroline J. Springer and Thomas Powles. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, The Breast and Oncology and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.